US69376K1060 - Common Stock

Overall **PX** gets a fundamental rating of **3** out of 10. We evaluated **PX** against 212 industry peers in the **Capital Markets** industry. **PX** may be in some trouble as it scores bad on both profitability and health. **PX** has a decent growth rate and is not valued too expensively.

In the past year **PX** was profitable.

In the past year **PX** had a positive cash flow from operations.

In the past 5 years **PX** always reported a positive cash flow from operatings.

Looking at the **Return On Invested Capital**, with a value of **3.14%**, **PX** is doing worse than **66.67%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **PX** is below the industry average of **8.43%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.33% | ||

ROE | -0.76% | ||

ROIC | 3.14% |

ROA(3y)1.35%

ROA(5y)2.77%

ROE(3y)2.64%

ROE(5y)15.92%

ROIC(3y)4.08%

ROIC(5y)3.83%

The **Profit Margin** and **Gross Margin** are not available for **PX** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 11.23% | ||

PM (TTM) | N/A | ||

GM | N/A |

OM growth 3Y-12.48%

OM growth 5Y-16.12%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **PX** has been increased compared to 1 year ago.

Based on the Altman-Z score of **1.16**, we must say that **PX** is in the distress zone and has some risk of bankruptcy.

The Debt to FCF ratio of **PX** is **8.57**, which is on the high side as it means it would take **PX**, **8.57** years of fcf income to pay off all of its debts.

The **Debt to FCF ratio** of **PX** (**8.57**) is comparable to the rest of the industry.

The **Debt to Equity ratio** of **PX** (**0.87**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.87 | ||

Debt/FCF | 8.57 | ||

Altman-Z | 1.16 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **0.80** indicates that **PX** may have some problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **0.80**, **PX** is doing worse than **65.24%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.8 | ||

Quick Ratio | 0.8 |

The **Earnings Per Share** has been growing slightly by **1.20%** over the past year.

Looking at the last year, **PX** shows a quite strong growth in **Revenue**. The Revenue has grown by **18.01%** in the last year.

The **Revenue** has been growing by **48.83%** on average over the past years. This is a very strong growth!

EPS 1Y (TTM)1.2%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

Revenue 1Y (TTM)18.01%

Revenue growth 3Y53.07%

Revenue growth 5Y48.83%

Sales Q2Q%15.48%

The **Earnings Per Share** is expected to grow by **9.93%** on average over the next years. This is quite good.

EPS Next Y0.55%

EPS Next 2Y5.74%

EPS Next 3Y9.93%

EPS Next 5YN/A

Revenue Next Year10.17%

Revenue Next 2Y8.21%

Revenue Next 3Y9.02%

Revenue Next 5YN/A

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The **Price/Earnings** ratio is **9.75**, which indicates a very decent valuation of **PX**.

71.90% of the companies in the same industry are more expensive than **PX**, based on the **Price/Earnings** ratio.

With a **Price/Forward Earnings** ratio of **8.72**, the valuation of **PX** can be described as very reasonable.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.75 | ||

Fwd PE | 8.72 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 25.26 | ||

EV/EBITDA | 20.84 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates **PX** does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)17.8

PEG (5Y)N/A

EPS Next 2Y5.74%

EPS Next 3Y9.93%

With a **Yearly Dividend Yield** of **1.64%**, **PX** has a reasonable but not impressive dividend return.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.64% |

Dividend Growth(5Y)N/A

Div Incr Years1

Div Non Decr Years1

DP-555.29%

EPS Next 2Y5.74%

EPS Next 3Y9.93%

**P10 INC-A**

NYSE:PX (5/30/2024, 10:29:56 AM)

**8.19**

**+0.14 (+1.74%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap925.63M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.64% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 9.75 | ||

Fwd PE | 8.72 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)17.8

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -0.33% | ||

ROE | -0.76% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 11.23% | ||

PM (TTM) | N/A | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.3

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.87 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.8 | ||

Quick Ratio | 0.8 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)1.2%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y0.55%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)18.01%

Revenue growth 3Y53.07%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y